Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP519361.RAv_bgMabkRCcJOvoaLxBYTFD6LvhX1ZR3OFVtrgFBl50130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP519361.RAv_bgMabkRCcJOvoaLxBYTFD6LvhX1ZR3OFVtrgFBl50130_assertion type Assertion NP519361.RAv_bgMabkRCcJOvoaLxBYTFD6LvhX1ZR3OFVtrgFBl50130_head.
- NP519361.RAv_bgMabkRCcJOvoaLxBYTFD6LvhX1ZR3OFVtrgFBl50130_assertion wasGeneratedBy ECO_0000203 NP519361.RAv_bgMabkRCcJOvoaLxBYTFD6LvhX1ZR3OFVtrgFBl50130_provenance.
- NP519361.RAv_bgMabkRCcJOvoaLxBYTFD6LvhX1ZR3OFVtrgFBl50130_assertion wasDerivedFrom befree-20150227 NP519361.RAv_bgMabkRCcJOvoaLxBYTFD6LvhX1ZR3OFVtrgFBl50130_provenance.
- NP519361.RAv_bgMabkRCcJOvoaLxBYTFD6LvhX1ZR3OFVtrgFBl50130_assertion SIO_000772 16810614 NP519361.RAv_bgMabkRCcJOvoaLxBYTFD6LvhX1ZR3OFVtrgFBl50130_provenance.
- NP519361.RAv_bgMabkRCcJOvoaLxBYTFD6LvhX1ZR3OFVtrgFBl50130_assertion evidence source_evidence_literature NP519361.RAv_bgMabkRCcJOvoaLxBYTFD6LvhX1ZR3OFVtrgFBl50130_provenance.
- NP519361.RAv_bgMabkRCcJOvoaLxBYTFD6LvhX1ZR3OFVtrgFBl50130_assertion description "[Depending on the biological background of individual patients, heterozygous and homozygous JAK2 V617F ET/PV may preferentially induce myeloid metaplasia with myelofibrosis with a relative suppression of megakaryocytic and erythropoietic myeloproliferation leading to clinical pictures of fibrotic chronic idiopathic myelofibrosis (CIMF) or agnogenic myeloid metaplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519361.RAv_bgMabkRCcJOvoaLxBYTFD6LvhX1ZR3OFVtrgFBl50130_provenance.